A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Condition:   Irritable Bowel Syndrome Interventions:   Drug: 25mg Eluxadoline;   Drug: 100mg Eluxadoline Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials